Skip to menu Skip to content Skip to footer
Professor Kesh Baboolal
Professor

Kesh Baboolal

Email: 

Overview

Background

Professor Kesh Baboolal is registered with both the Australian Medical Board and General Medical Council UK as a Nephrologist and Physician in Internal Medicine. He was awarded FRACP and FRCP from the Royal College of Physicians in both the Australia and the UK. He is currently a consultant nephrologist and general physician at the Royal Brisbane and Women's Hospital. He has a sub specialist interest in renal transplantation.

Professor Baboolal graduated from St Thomas’s Hospital, University of London. He undertook post-graduate training at the Nuffield Department of Medicine in Oxford and Guys and St Thomas’ Hospital, London. He was awarded a Juvenile Diabetes International Research Fellow at Stanford University, where he undertook a clinical and research fellowship in Nephrology from 1990-95. He completed his doctorate degree, Doctor of Medicine (MD) and was subsequently appointed as a consultant in nephrology, renal transplantation and general medicine in 1997 at the University Hospital of Wales UK, where he worked until 2012. In 2012 he moved with his family to Australia.

In 2003, Professor Baboolal successfully completed an LLM in Legal Aspects of Medical Practice from Cardiff University Law School. His dissertation entitled “My body as my property” explored whether property rights exist in the body and whether the development of property rights would provide a legal framework to design legislation that regulates organ donation and transplantation.

In 2006, he completed an eMBA program at INSEAD Paris which, together with the European Health Leadership Program at INSEAD, has provided him with the business knowledge and leadership skills required for senior leadership in healthcare services.

Throughout his clinical career, Professor Keshwar Baboolal has maintained a number of interests related to his specialist clinical experience, including:

Research

An active research program in areas related to nephrology, transplantation and health economics. He has published extensively in leading international peer reviewed journals. He has also received peer-reviewed grants, lectured at national and international meetings and has been on editorial boards of international medical journals.

Medico-Legal Interests

Professor Baboolal has helped develop clinical, ethical and regulatory guidelines for many aspects of transplantation in the UK on behalf of the UK Government, UK Department of Health, UK Royal Colleges and Professional Bodies including the British Transplant Society.

Medical Leadership

Professor Baboolal has undertaken a number of medical leadership roles in the UK and Australia. Using the business knowledge and leadership skills together with his clinical knowledge and experience, Professor Baboolal has taken forward a number of initiatives that have redefined and improved clinical services to deliver efficient, high quality services that meet the needs of patients and their families

Availability

Professor Kesh Baboolal is:
Available for supervision

Research impacts

Renal Research

Professor Keshwar was awarded a National Kidney Research Fellowship and Juvenile Diabetes Foundation International Research Fellowship in the Division of Nephrology at Stanford University, California from 1992-1995. He studied the role of the renin angiotensin system in models of progressive renal disease. I have led a research group of post doctorate scientists, clinician trainees and MD candidates that has explored the role of the renin angiotensin system in human renal disease.

Within transplantation Professor Baboolal has studied and explored the molecular determinants of renal allograft nephropathy as well as explored the pathophysiology of new onset diabetes after transplantation. This work has included laboratory based basic science research, clinical research involving complex physiology measurements in humans and clinical trials. With regards to clinical trials he has been both a principal investigator and supported multicentre international investigations. The work has been funded through a number of peer reviewed competive research grants. The outputs of this work have been published in International peer reviewed journals, presented at International Meetings as both invited speakers and as abstracts.

Health Economics

More recently Professor Baboolal has developed a research interest in healthcare economics related to renal disease and transplantation.

As a consequence of this work he has been asked to provide expert advice to N.I.C.E. (National Institute of Clinical Excellence) and the Department of Health UK to help set the National Tariff for renal replacement therapy in the UK.

Operational Research.

Professor Baboolal created an Operational Research Unit in collaboration with the School of Mathematics at Cardiff University. The work used operational sciences including modelling and forecasting to help optimise the design of clinical services and systems, particulary in Emergency Departments

Ethical and Regulatory Guidelines Related to Transplantation

Professor Baboolal has also been involved in developing clinical, ethical and regulatory guidelines for many aspects of transplantation.

  • Advisor to the Human Tissue Authority: I have provided professional advice to the Authority on the implementation of the Human Tissue Act and provided clinical advice on the interpretation of the Act in complex clinical cases referred to the Authority.
  • Appointed Member of the Department of Health Advisory Board for the Safety of Blood Tissues and Organs. This National Policy Advice Group is charged with developing advice to Parliament to ensure the safe supply of tissues for medical use and research.
  • Appointed member to the UK Academy of Royal Colleges Ethics Committee. This committee provides ethical guidance on issues related to organ donation and transplantation.
  • Co-author of Ethical Guidance for Deceased Cardiac Death Donation. UK Academy of Royal Colleges Ethics Committee
  • Member of the British Transplant Society Ethics Committee 2004-2006
  • Co-author of British Transplant Society Guidelines with regards to consent for organ donation.
  • Advice to the Scottish Parliament on the new legal framework for organ donation in the UK.

Works

Search Professor Kesh Baboolal’s works on UQ eSpace

58 works between 1994 and 2022

41 - 58 of 58 works

2008

Journal Article

Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia

Sharif, Adnan, Moore, Richard and Baboolal, Keshwar (2008). Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation, 85 (3), 353-358. doi: 10.1097/TP.0b013e3181605ebf

Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia

2008

Journal Article

Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE)

Warrens, A. N., Baboolal, K., Buist, L., Dudley, C., Koffman, G., Lipkin, G., Parrott, N., Powis, S. H., Sweny, P. and Raftery, M. (2008). Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE). Clinical Nephrology, 69 (2), 67-76. doi: 10.5414/CNP69067

Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE)

2006

Journal Article

Use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon

Sharif, Adnan, Moore, Richard H. and Baboolal, Keshwar (2006). Use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation, 82 (12), 1667-1672. doi: 10.1097/01.tp.0000250924.99855.42

Use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon

2004

Conference Publication

Six month interim analysis of a phase III prospective, randomised study to compare conversion from calcineurin inhibitors to Rapamycin in established renal allograft recipients with mild to moderate renal insufficiency

Baboolal, K (2004). Six month interim analysis of a phase III prospective, randomised study to compare conversion from calcineurin inhibitors to Rapamycin in established renal allograft recipients with mild to moderate renal insufficiency. American Transplant Congress, Boston Ma, May 14-19, 2004. COPENHAGEN: BLACKWELL MUNKSGAARD.

Six month interim analysis of a phase III prospective, randomised study to compare conversion from calcineurin inhibitors to Rapamycin in established renal allograft recipients with mild to moderate renal insufficiency

1999

Conference Publication

What is the true incidence of acute rejection (AR) in renal transplant recipients receiving calcineurin inhibitors?

Morris-Stift, G, Griffiths, D, Jones, D, Quiroga, , Baboo, R, Singh, J, Stockdill, H, Jones, GV, Janezic, A, Baboolal, K and Jurewicz, WA (1999). What is the true incidence of acute rejection (AR) in renal transplant recipients receiving calcineurin inhibitors?. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007890-199905150-00042

What is the true incidence of acute rejection (AR) in renal transplant recipients receiving calcineurin inhibitors?

1999

Conference Publication

New onset symptomatic oesophago-gastric disease following renal transplantation: Endoscopic findings in the modern immunosuppressive Era

Logan, A, Morris-Stiff, G, Bowrey, DJ, Singh, J, Jones, GV, Janezic, A, Baboolal, K and Jurewicz, WA (1999). New onset symptomatic oesophago-gastric disease following renal transplantation: Endoscopic findings in the modern immunosuppressive Era. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007890-199905150-00352

New onset symptomatic oesophago-gastric disease following renal transplantation: Endoscopic findings in the modern immunosuppressive Era

1999

Conference Publication

Is homocysteine an important risk factor for the transplant recipient?

Quiroga, , Morris-Stiff, G, Baboo, R, Stockdill, H, Singh, J, Jones, GV, Janezic, A, Oleesky, D, McDowell, , Baboolal, K and Jurewicz, WA (1999). Is homocysteine an important risk factor for the transplant recipient?. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007890-199905150-00337

Is homocysteine an important risk factor for the transplant recipient?

1999

Conference Publication

Blood pressure and left ventricular mass (LVM) changes following renal transplantation in patients receiving calcineurin inhibitors

Barr, C, Buchalter, M, Morris-Stiff, G, Singh, J, Quiroga, , Baboo, R, Stockdill, H, Baboolal, K and Jurewicz, WA (1999). Blood pressure and left ventricular mass (LVM) changes following renal transplantation in patients receiving calcineurin inhibitors. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007890-199905150-00317

Blood pressure and left ventricular mass (LVM) changes following renal transplantation in patients receiving calcineurin inhibitors

1999

Conference Publication

Sequential assessment of non-immunological risk factors for the development of chronic graft nephropathy comparison of prograf & neoral regimes

Baboo, R, Morris-Stiff, G, Quiroga, , Singh, J, Stockdill, H, Jones, GV, Janezic, A, Baboolal, K and Jurewiez, WA (1999). Sequential assessment of non-immunological risk factors for the development of chronic graft nephropathy comparison of prograf & neoral regimes. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00007890-199905150-00355

Sequential assessment of non-immunological risk factors for the development of chronic graft nephropathy comparison of prograf & neoral regimes

1998

Journal Article

Conversion of renal transplant recipients from cyclosporin (Neoral) to tacrolimus (Prograf) for haemolytic uraemic syndrome

Morris-Stiff, G., Talbot, D., Balaji, V., Baboolal, K., Callanan, K., Hails, J., Moore, R., Manas, D., Lord, R. and Jurewicz, W. A. (1998). Conversion of renal transplant recipients from cyclosporin (Neoral) to tacrolimus (Prograf) for haemolytic uraemic syndrome. Transplant International, 11 (SUPPL. 1). doi: 10.1111/j.1432-2277.1998.tb01206.x

Conversion of renal transplant recipients from cyclosporin (Neoral) to tacrolimus (Prograf) for haemolytic uraemic syndrome

1998

Journal Article

Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection

Morris-Stiff, G., Talbot, D., Balaji, V., Baboolal, K., Callanan, K., Hails, J., Moore, R., Manas, D., Lord, R. and Jurewicz, W. A. (1998). Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection. Transplant International, 11 (SUPPL. 1). doi: 10.1111/j.1432-2277.1998.tb01201.x

Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection

1997

Conference Publication

Association of the ACE gene deletion polymorphism and early onset of ESRF in PKD1 ADPKD

Baboolal, K, Ravine, D, Daniels, J, Coles, GA and Williams, JD (1997). Association of the ACE gene deletion polymorphism and early onset of ESRF in PKD1 ADPKD. MALDEN: BLACKWELL SCIENCE INC.

Association of the ACE gene deletion polymorphism and early onset of ESRF in PKD1 ADPKD

1997

Conference Publication

Structural determinants of ultrafiltration coefficient in early diabetic nephropathy

Baboolal, K, Coles, GA and Williams, JD (1997). Structural determinants of ultrafiltration coefficient in early diabetic nephropathy. MALDEN: BLACKWELL SCIENCE INC.

Structural determinants of ultrafiltration coefficient in early diabetic nephropathy

1997

Journal Article

Conversion from cyclosporin to tacrolimus in a patient with prolonged acute tubular necrosis

MorrisStiff, G, Jurewicz, A, Balaji, , Baboolal, K, Moore, R, Griffin, P and Lord, R (1997). Conversion from cyclosporin to tacrolimus in a patient with prolonged acute tubular necrosis. Transplant International, 10 (5), 398-400. doi: 10.1111/j.1432-2277.1997.tb00937.x

Conversion from cyclosporin to tacrolimus in a patient with prolonged acute tubular necrosis

1996

Conference Publication

Ace gene polymorphism in patients with PKD1 autosomal dominant polycystic kidney disease (PKD1 ADPKD)

Baboolal, K, Daniels, J, Ravine, D, Coles, GA and Williams, JD (1996). Ace gene polymorphism in patients with PKD1 autosomal dominant polycystic kidney disease (PKD1 ADPKD). WASHINGTON: AMER SOC NEPHROLOGY.

Ace gene polymorphism in patients with PKD1 autosomal dominant polycystic kidney disease (PKD1 ADPKD)

1996

Journal Article

Haemolytic uraemic syndrome associated with OKT3

MorrisStiff, G, Evans, M, Baboolal, K, Balaji, , Moore, R, Jurewicz, A and Lord, R (1996). Haemolytic uraemic syndrome associated with OKT3. Transplant International, 9 (5), 522-523. doi: 10.1007/BF00336835

Haemolytic uraemic syndrome associated with OKT3

1995

Journal Article

TUBULOINTERSTITIAL INJURY AND IMPAIRED RENAL-FUNCTION AFTER RECOVERY FROM ACUTE PUROMYCIN NEPHROSIS

BABOOLAL, K and MEYER, TW (1995). TUBULOINTERSTITIAL INJURY AND IMPAIRED RENAL-FUNCTION AFTER RECOVERY FROM ACUTE PUROMYCIN NEPHROSIS. American Journal of Physiology-Renal Fluid and Electrolyte Physiology, 269 (3), F331-F338. doi: 10.1152/ajprenal.1995.269.3.F331

TUBULOINTERSTITIAL INJURY AND IMPAIRED RENAL-FUNCTION AFTER RECOVERY FROM ACUTE PUROMYCIN NEPHROSIS

1994

Conference Publication

CHRONIC RENAL INJURY FOLLOWING RECOVERY FROM ACUTE PUROMYCIN (PAN) NEPHROSIS

BABOOLAL, K and MEYER, TW (1994). CHRONIC RENAL INJURY FOLLOWING RECOVERY FROM ACUTE PUROMYCIN (PAN) NEPHROSIS. BALTIMORE: WILLIAMS & WILKINS.

CHRONIC RENAL INJURY FOLLOWING RECOVERY FROM ACUTE PUROMYCIN (PAN) NEPHROSIS

Supervision

Availability

Professor Kesh Baboolal is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Kesh Baboolal's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au